PT  - JOURNAL ARTICLE
AU  - Rajeshbhai, Sabara Parshad
AU  - Dhar, Subhra Sankar
AU - Shalabh
TI  - Statistical Forecasting : Third Wave of COVID-19-With an Application to India
AID  - 10.1101/2021.12.20.21268150
DP  - 2021 Jan 01
TA  - medRxiv
PG  - 2021.12.20.21268150
4099  - http://medrxiv.org/content/early/2021/12/21/2021.12.20.21268150.short
4100  - http://medrxiv.org/content/early/2021/12/21/2021.12.20.21268150.full
AB  - The pandemic due to the SARS-CoV-2 virus impacted the entire world in different waves. An important question that arise after witnessing the first and second waves of COVID-19 is - Will the third wave also arrive and if yes, then when. Various types of methodologies are being used to explore the arrival of third wave. A statistical methodology based on the fitting of mixture of Gaussian distributions is explored in this paper and the aim is to forecast the third wave using the data on the first two waves of pandemic. Utilizing the data of different countries that are already facing the third wave, modelling of their daily cases data and predicting the impact and timeline for the third wave in India is attempted in this paper. The Gaussian mixture model based on algorithm for clustering is used to estimate the parameters.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe authors gratefully acknowledges the support from the MATRICS project from Science and Engineering Research Board (SERB), Department of Science and Technology, Government of India.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.Yeshttps://ourworldindata.org/coronavirus https://ourworldindata.org/coronavirus